Roy Winston

All filings by Roy Winston on record concern Pacira BioSciences, Inc., in the capacity of chief executive. The record holds 29 filings, for trades running from 4 June 2019 to 2 August 2023.

Market trades split into 1 purchase (€81k) and 19 sales (€2.9M). Taken together, the sales exceed the purchases by €2.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants and 3 option exercises. In 2023 alone, the filings show no purchases and 3 sales.

The record was last updated on 4 August 2023 with an open-market sale (€16k) in Pacira BioSciences, Inc. The most recent open-market purchase was published on 12 March 2020, 2,433 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.